Objective: This preliminary study was conducted to establish the minimal counseling requirements for buprenorphine maintenance in primary care settings. A brief, nurse-administered, medically focused counseling approach for buprenorphinemaintained patients, Medical Management (MM), was designed by the authors. To evaluate preliminary feasibility and efficacy of MM prior to using it in a primary care setting, we evaluated it in a methadone maintenance program. 
F
or some opioid dependent patients, buprenorphine (BUP) is an alternative to methadone for opioid agonist maintenance treatment, in that it: (1) allows for less-thandaily dosing; (2) has lower abuse and diversion liability, especially with BUP/Naloxone combination tablet; and (3) can more easily be provided outside of traditional maintenance clinics. These properties of BUP may allow for broader accessibility of agonist maintenance treatment to the approximately 600,000 untreated opioid dependent individuals in the United States, especially with the Food and Drug Administration (FDA) approval of BUP and the Federal Drug Abuse Treatment Act of 2000 (DATA), which allow for the provision of BUP maintenance in primary care settings by specially-trained primary care physicians. 1 In general, broadening the base of treatment options for these patients allows for more treatment sites, a broader range of sites, more practitioners, and potentially briefer and more effective treatments. This is of particular importance for primary care physicians, given the recent calls by a number of organizations for increased involvement on their part in treating heroin dependence. 2, 3 However, as BUP maintenance is provided and evaluated in primary care settings, the level of counseling required to allow it to be effective outside of traditional maintenance clinics becomes a critical issue, one in need of evaluation. Studies have found that the combination of drug counseling and opioid agonist maintenance is superior to opioid agonist maintenance treatment alone. For example, McLellan and his colleagues 4 found that, for methadonemaintained patients in a traditional maintenance clinic, enhanced drug counseling was superior to minimal (standard) counseling, but less cost-effective than a moderateintensity treatment. If brief and effective, nurse-administered counseling approaches can be developed for treating BUP maintained patients, then such a combination of pharmacologic and psychosocial treatments may be feasible for use in primary care settings.
The primary objective of the current study was to conduct a preliminary test of the feasibility and efficacy of MM, compared with MM+DC, during thrice-weekly BUP maintenance in a methadone maintenance program. Though intended for use in later studies of BUP in primary care settings (which are currently on-going), MM was conducted in a methadone maintenance program in the current study to initially test it in a setting where more intensive treatment, if necessary, would be readily available. Once the preliminary feasibility and efficacy of this approach was established, then a test in a primary care setting would be warranted. Thus, as in McLellan's study, we evaluated level or intensity of counseling needed during agonist maintenance treatment.
HYPOTHESIS
The hypothesis of the current study was that MM+DC would be more effective than MM alone for retaining patients in treatment, and reducing illicit opiate use and its negative psychosocial and medical consequences. This hypothesis was made based on McLellan's work, which indicated that the addition of drug counseling enhanced minimal counseling.
MATERIALS AND METHODS

Subjects
Subjects were 14 individuals over the age of 21 seeking opioid agonist maintenance treatment of opioid dependence at a methadone maintenance program and who met the following eligibility criteria: (1) Diagnostic and Statistical Manual-Fourth Edition (DSM-IV) 5 criteria for opioid dependence based on the Structured Clinical Interview for the DSM-IV (SCID) 6 ; (2) opioid-positive urine toxicology; (3) Federal Drug Administration criteria for methadone maintenance treatment; (4) no current dependence on alcohol, cocaine, or benzodiazepines or sedatives; (5) no current suicide or homicide risk; (6) no acute medical or psychiatric conditions; (7) ability to read or understand English; and (8) women agreeing to adequate contraception and to monthly pregnancy monitoring throughout the study.
Treatments
BUP Maintenance
BUP was provided using the mono tablet (buprenorphine alone/without naloxone), which was administered sublingually (see Dosing Schedule, Table 1 ). The 12-week dosing protocol, which included induction, maintenance, and detoxification, allowed for 2 dose upgrades to 28 mg, 28mg, 40 mg for the first upgrade and 32 mg, 32 mg, 48 mg for the second upgrade. The dose of BUP was increased for continued positive urine toxicology or patient discomfort due to withdrawal.
MM Counseling
MM was provided in thrice-weekly, 5-10 minute sessions, twice per week at the dispensing window of a methadone maintenance program and once per week in the RN's office. We used an RN as a counselor, given the presence of RNs in most primary Pantalon et al care settings. The MM manual was based on the Clinical Management manual used in the National Institute of Mental Health Collaborative Depression Study, in which nurses administered brief counseling to patients receiving antidepressant medication, 7 and was designed to approximate counseling/education provided to patients for common chronic medical conditions treated in primary care (PC). Specifically, in MM, RNs: (1) established a therapeutic alliance; (2) educated patients about opioid dependence and BUP maintenance treatment, including complications of opioid and other illicit drug use; (3) monitored drug use and urine toxicology results; (4) encouraged participation in selfhelp groups; and (5) gave brief advice for achieving abstinence.
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ADDICTIVE DISORDERS & THEIR TREATMENT
Training in MM
Training in MM consisted of 3, 90-minute didactic sessions on (1) opioid dependence, (2) BUP pharmacology, and (3) brief counseling and motivational interviewing 8 techniques. Nurses were given an MM manual (available from Dr Pantalon) to guide their sessions with clients, and participated in a weekly supervision meeting, during which manual adherence and counseling issues were reviewed with a supervising psychologist (Dr Pantalon).
DC
DC was provided in weekly, 45-minute, individual, sessions by a Ph.D.-level psychologist or an experienced drug counselor, using a standardized treatment manual adapted for individual sessions. 9 DC is a treatment in which patients are taught about the spiritual (eg, acknowledging the existence of a higher power), physical (eg, sleep disturbances), psychological (eg, denial), emotional (eg, stress, anger), and interpersonal (eg, codependence) factors that play a role in the development of and recovery from substance dependence. Sessions focus on encouraging lifestyle changes (eg, increasing engagement in healthy activities, staying away from the people, places, and things which trigger drug use) and teaching coping skills (eg, preventing relapse, managing negative affect). DC also strongly encourages active participation in 12-step groups (eg, Narcotics Anonymous). DC is an effective, and widely employed and studied psychosocial approach to treating opiate dependent individuals, especially in community-based methadone maintenance programs, and is frequently a standard component in psychotherapy trials for opioid 4, 10, 11 as well as cocaine dependent individuals. 12 It has been shown to be more effective than minimal methadone services (ie, medication management) in terms of 4 DC also has demonstrated efficacy with individuals on BUP maintenance.
10,11
Treatment Setting
The study was performed in the Legion Avenue Methadone Maintenance Program of the APT Foundation, Inc., an urban, academically affiliated provider of drug treatment. The study protocol was approved by the Human Investigation Committee of the Yale University School of Medicine.
Design
Fourteen opioid-dependent patients meeting the eligibility criteria described above were treated for 12 weeks with thriceweekly BUP plus either MM or MM+DC. Assignment to treatment condition was random, except for the first 3 subjects who were assigned to MM due to lack of drug counselor availability.
Outcome Measures
Outcome measures were (1) treatment retention (ie, number of subjects who completed 12 weeks of treatment), (2) the proportion of opioid-positive urine toxicology tests, and (3) the number of subjects who achieved 3 or more consecutive weeks of opioid-negative urine toxicology tests.
Data Analyses
Baseline characteristics and outcomes were compared using the 2 for dichotomous variables and the independent student's t test for continuous variables. Table 2 , there were no differences between the two treatment groups on baseline demographic or addiction severity variables. Table 3 indicates that all 7 of the MM and 6 of the 7 MM+DC patients completed all 12 weeks of the study. Overall, the proportion of opioid-positive urine toxicology tests was 72% for MM and 54% for MM+DC. Two of the 7 MM and 4 of the 7 MM+DC patients achieved Ն3 consecutive weeks of opioid-negative urine toxicology tests. However, none of these tests reached statistical significance (see Table 3 ).
RESULTS
As shown in
DISCUSSION
This preliminary study demonstrated the feasibility and efficacy of MM as a promising counseling approach for BUP maintenance. MM produced good levels of treatment retention and demonstrated reduction in illicit opioid use as evidenced by urine toxicology analysis. A consistent trend favoring the addition of DC to MM, in comparison to MM alone, supports need for DC even for these "good prognosis" patients (those with no other comorbid drug or psychiatric problems). Though suggestive of the superiority of the MM+DC condition, none of the statistical tests reached significance, likely due to the small sample size.
The results also suggest, as with methadone, that DC may be a necessary component of BUP treatment of opioid dependence. Therefore, tests of the efficacy of counseling approaches for use with BUP maintenance in primary care settings may need to incorpo- However, while MM in this study did not fare as well as MM+DC, it led to better drug use outcomes than the standard minimal counseling in McLellan's study. This can possibly be explained by the facts that (1) MM, though brief, provided considerably more than the "minimal" intervention provided in McLellan's 1993 study, and (2) the current study's sample was less severe and more homogeneous than those in the McLellan study (ie, "poor prognosis" patients, such as those with concurrent cocaine abuse or dependence and psychiatric disorders, were excluded from the current study).
Limitations
The main limitations of this study are its preliminary nature, small sample size, and lack of full randomization to treatment conditions, all of which point to the critical need for replication of the findings. It remains unclear whether the findings of the current study are generalizable to the larger population of office-based BUP treatment-seeking, opioid-dependent individuals generally. Additionally, because of logistical issues, including space, time, and staffing resources, we were only able to provide 1 out of the 3 weekly MM sessions in an office. The other 2 sessions were provided at the medication window of the methodone maintenance program. Having two-thirds of the MM sessions in this less than completely private setting may have lessened its therapeutic impact by, for example, preventing disclosure of relevant personal issues. The additive design, which makes it unclear whether DC per se, versus extra attention, for example, accounted for the differences in outcome between MM and MM+DC, could be considered a weakness as well. Finally, the study was conducted during the early stages of MM manual development.
Continued Development of MM for Use in Primary Care
As noted earlier, although we ultimately wanted to use MM for BUP-maintained patients in primary care settings, we felt that this was premature at the time the current study was initiated. However, given the positive results of this study on the preliminary feasibility and efficacy of this approach in the MMP, we proceeded to continue its development and test it in a primary care setting.
Following completion of this study, the MM manual and training program were revised to focus more explicitly on: (1) standard topics covered in the DC, 9 (2) devising treatment plans, (3) handling difficult situations/patients, (4) increasing participation in NA and other self-help groups, and (5) presenting advice and feedback in a motivational manner. When the revised MM was tested in a large, university-affiliated, urban primary care center (PC), outcomes were improved. 13 For example, in the PC, MM alone led to 58% opioid-positive urine toxicology results versus 72% in the current study. Further, 3 out of 7 (42.9%) MM patients achieved 3 or more weeks of consecutive opioid abstinence in the PC study, compared with 2 out of 7 (28.6%) in the current study. An enhanced MM manual (EMM) has also been developed and includes more intensive instruction on the critical aspects of the drug counseling components (eg, with longer, 45-minute sessions, handouts and worksheets given for homework between sessions). A randomized controlled clinical trial in our PC, comparing the efficacy of BUP maintenance plus standard MM or EMM, in addition to varying frequencies of required visits to the clinic to pick up the medication, is on-going.
In conclusion, effective BUP counseling in primary care settings may require physicians and nurses to incorporate aspects of both standard MM, as well as evidence-based DC approaches.
